Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › idiopathic short stature

Idiopathic short stature

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for idiopathic short stature

7 trials tracked for idiopathic short stature: 6 in phase 3 or 4 and 3 with published results. The most-cited published study has 99 citations.

7Trials tracked
6Phase 3 & 4
0Recruiting
3With published results
Phase distribution
Phase 3 6 Other / NA 1
  1. Phase 3 Aromatase Inhibitors, Alone And In Combination With Growth Hormone In Adolescent Boys With Idiopathic Short Stature Completed · 99 cited
  2. Phase 3 A Phase 3 Study to Evaluate the Safety and Efficacy of Saizen® in Children With Idiopathic Short Stature (ISS) Completed · 12 cited
  3. Phase 3 Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short Stature Completed · 5 cited
  4. Phase 3 Efficacy and Safety of DA-3002 in Children With Idiopathic Short Stature Completed
  5. Phase 3 Genotropin Study Assessing Use of Injection Pen Completed
  6. Phase 3 Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature Completed
Show 1 more trials
  1. N/A Ghrelin Levels in Children With Poor Growth Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Meta-analysis finds growth hormone therapy shows no significant ocular biometric changes in idiopathic short stature
Pediatrics Meta-analysis
Meta-analysis finds growth hormone therapy shows no significant ocular biometric changes in idiopathic short stature Growth hormone therapy shows possible link to refractive changes in children with short stature
This systematic review and meta-analysis of nine studies evaluated growth hormone therapy in children with idiopathic short stature.
Growth hormone therapy in children with short stature may change how their eyes focus light, though other eye measurements remain stable.
Apr 17, 2026